Lifestyle Medical Network (LMNK) 10-Q 23 Aug 16 2016 Q2 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	6 Months Ended
	Jun. 30, 2016	Aug. 22, 2016
Document and Entity Information [Abstract]
Entity Registrant Name	LIFESTYLE MEDICAL NETWORK, INC.
Entity Central Index Key	1,307,140
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Document Type	10-Q
Document Period End Date	Jun. 30, 2016
Document Fiscal Period Focus	Q2
Document Fiscal Year Focus	2,016
Entity Filer Category	Smaller Reporting Company
Entity Common Stock, Shares Outstanding		33,958,257

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($)	Jun. 30, 2016	Dec. 31, 2015
CURRENT ASSETS:
Cash and cash equivalents	$ 27,147	$ 49,719
Accounts receivable-related party	516,100	516,868
Loan receivable-related party	610,181	100,000
Prepaid expenses	18,250	53,107
Total Current Assets	1,171,678	719,694
Property, plant and equipment - net	376,861	134,296
Intangible assets - net	80,562	83,338
TOTAL ASSETS	1,629,101	937,328
CURRENT LIABILITIES:
Accounts payable and accrued expenses	301,665	197,877
Notes payable	531,000	250,000
Convertible notes payable, net of $387,012 and $105,935 debt discount	728,508	644,065
Total Current Liabilities	1,561,173	1,091,942
Commitments and Contingencies
STOCKHOLDERS' EQUITY (DEFICIENCY):
Common stock, $.001 par value, 200,000,000 shares authorized; 33,958,257 and 33,658,257 shares issued and outstanding at June 30, 2016 and December 31, 2015, respectively	33,959	33,659
Additional paid-in-capital	9,702,517	9,172,696
Accumulated deficit	(9,668,548)	(9,360,969)
Total Stockholders' Equity (Deficiency)	67,928	(154,614)
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIENCY)	$ 1,629,101	$ 937,328

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parenthetical) - USD ($)	Jun. 30, 2016	Dec. 31, 2015
Balance Sheets
Net of debt discount	$ 387,012	$ 105,935
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares authorized	200,000,000	200,000,000
Common stock, shares issued	33,958,257	33,658,257
Common stock, shares outstanding	33,958,257	33,658,257

Consolidated Statements of Oper

Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2016	Jun. 30, 2015	Jun. 30, 2016	Jun. 30, 2015
Revenues:
Management fees-related party	$ 351,750	$ 163,500	$ 567,750	$ 163,500
Rental income-related party	110,250	103,483	213,750	103,483
Total revenues	462,000	266,983	781,500	266,983
Costs and expenses:
Cost of revenue related to management fees	170,644	29,784	304,607	29,784
Cost of revenue related to rental income	67,894	68,020	135,788	68,020
Selling, general and administrative expenses	161,484	169,253	329,514	211,152
Amortization of warrants	80,000	547,176	80,000	567,335
Total Costs and expenses	480,022	814,233	849,909	876,291
Loss from operations	(18,022)	(547,250)	(68,409)	(609,308)
Other income (expense):
Loss on extinguishment of debt	(61,697)		(61,697)
Other income			25,000
Interest expense	(115,948)	(22,325)	(202,473)	(32,450)
Total Other income (expense)	(177,645)	(22,325)	(239,170)	(32,450)
Loss from operations before provision for income taxes	(195,667)	(569,575)	(307,579)	(641,758)
Provision for income taxes
Net loss	$ (195,667)	$ (569,575)	$ (307,579)	$ (641,758)
Loss per common share-basic and diluted	$ 0	$ (0.02)	$ (0.01)	$ (0.02)
Weighted average common shares outstanding - basic and diluted	33,707,708	31,331,948	33,682,982	28,723,019

Consolidated Statements of Cash

Consolidated Statements of Cash Flows (Unaudited) - USD ($)	6 Months Ended
	Jun. 30, 2016	Jun. 30, 2015
Cash flows from operating activities:
Net loss	$ (307,579)	$ (641,758)
Adjustments to reconcile net loss to net cash used in operating activities:
Amortization	2,776	7,061
Depreciation	32,435	6,912
Loss on extinguishment of debt	61,697
Stock-based compensation	22,000
Amortization of warrants	80,000	567,335
Amortization of beneficial conversion feature	145,044
Changes in operating assets and liabilities:
Accounts receivable	768	(177,000)
Prepaid expenses	36,857	16,000
Accounts payable and accrued expenses	157,611	(18,758)
Net Cash Provided by (Used In) Operating Activities	231,609	(240,208)
Cash flows from investing activities:
Refund of deposit		100,000
Advances to related party	(775,181)	(135,000)
Repayments by related party	265,000	80,000
Purchase of equipment		(112,743)
Net Cash Used In Investing Activities	(510,181)	(67,743)
Cash flows from financing activities:
Proceeds from related parties		42,351
Repayment of related party debt		(142,351)
Repayment of short-term debt	(24,000)
Proceeds from short-term debt	280,000	600,000
Net Cash Provided by Financing Activities	256,000	500,000
Net increase (decrease) in cash	(22,572)	192,049
Cash and cash equivalents - Beginning of period	49,719	163
Cash and cash equivalents - End of period	27,147	192,212
Cash paid for:
Interest		28,750
Income taxes
Non-cash Investing and Financing Activities
Conversion of debt and interest for common stock		999,180
Equipment purchased with note payable	275,000
Issuance of common stock for services
Beneficial conversion feature	$ 426,121

Description of Business and Sum

Description of Business and Summary of Significant Accounting Policies	6 Months Ended
	Jun. 30, 2016
Description of Business and Summary of Significant Accounting Policies [Abstract]
DESCRIPTION OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	1. DESCRIPTION OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES The consolidated balance sheet as of June 30, 2016 and the consolidated statements of operations, stockholders' deficiency and cash flows for the periods presented have been prepared by Lifestyle Medical Network, Inc. and Subsidiaries (the "Company" or "Lifestyle") and are unaudited. The consolidated financial statements are prepared in accordance with the requirements for unaudited interim periods, and consequently, do not include all disclosures required to be made in conformity with accounting principles generally accepted in the United States of America. In the opinion of management, all adjustments (consisting solely of normal recurring adjustments) necessary to present fairly the financial position, results of operations, changes in stockholders' deficiency and cash flows for all periods presented have been made. The information for the consolidated balance sheet as of December 31, 2015 was derived from audited financial statements of the Company. Organization Lifestyle Medical Network Inc. and Subsidiaries (the “Company” or “Lifestyle”) was incorporated in the State of Nevada. The Company directs its operations through its subsidiaries. The Company, through its consulting subsidiaries, plans to continue to identify and enter into management and professional consulting services agreements, and to license medical and health technologies, to medical and health clinic operating companies. The Company also intends to open, operate and acquire medical and health clinics, if financing is available and the profile of the clinics’ is favorable. Material Agreements The Company entered management agreements, and have commenced recognizing revenues thereunder, with two medical professional associations located in Houston, Texas, MED-Cure Primary Care Physicians, P.A. and MED-CURE Anti-Aging and Skin Care, P.A. (the “MED-CURE Companies”), effective April 1, 2015, which were purchased by Dr. Ronald Moomaw, a director of the Company. The MED-CURE Companies between them operate six medical clinics in Houston, of which four are primary care clinics and two are skin care clinics. Under management agreements with the MED-CURE Companies, the Company, through its subsidiary LifeStyle Texas Medical Management, LLC (“LifeStyle Management”), provides organizational development, accounting, human resources, computer technical support compliance, scheduling, marketing and advertising, office space, equipment supplies and other management services and receives an agreed percentage of the gross revenues of the practice group, with adjustments designed to ensure that management fees do not exceed an agreed cap, or that the monthly payments do not result in an event of default under the acquisition financing documents for the MED-CURE Companies. The leasing arrangements for the properties leased for the MED-CURE Companies’ clinics’ offices were restructured, with our real estate subsidiary, LifeStyle Texas Real Estate. LLC, leasing the properties and then subleasing the properties back to the MED-CURE Companies. Through our subsidiary, Regional Professional Alliance, Inc. , a physician’s professional consulting company that provides professional medical consulting services to medical management companies related to matters affecting professional licensure and medical clinic compliance matters for the benefit of clinics managed by Lifestyle Management, we have entered into an agreement with Dr. Moomaw to provide services through Regional Professional Alliance for the benefit of LifeStyle Management related to oversight and professional medical services coordination of the managed clinics which have entered into management services agreements with LifeStyle Management. Through LifeStyle Texas Licensing, LLC (“LifeStyle Licensing”), the Company plans to sublicense to the MED-CURE Companies the non-exclusive right to use, and to sublicense the use of, certain patents, trademarks, trade names, logos, slogans, trade dress, commercial symbols, operational systems, and other intellectual property rights, in connection with operating and managing medical clinics that provide medical services and/or products of a character and quality, in particular relating to men’s health and weight management. Going Concern The consolidated financial statements for the period ended June 30, 2016 have been prepared on a going concern basis which contemplates the realization of assets and the settlement of liabilities and commitments in the normal course of business. The Company has a past history of recurring losses from operations and is a development stage company. The Company will require additional funding to execute its future strategic business plan. Successful business operations and its transition to attaining profitability are dependent upon obtaining additional financing and achieving a level of revenue to support its cost structure. These factors raise substantial doubt about the Company's ability to continue as a going concern. The Company has entered into Management agreements with six medical clinics in Houston, Texas. The Company will provide services to the clinic and will receive an agreed percentage of gross revenues of the practice group. Management intends to make further acquisitions of other medical clinics during 2016. Management believes these acquisitions will be profitable and the cash flows from these operations will enable the Company to fund the operations of the consolidated group over the next twelve months. Therefore, the annual financial statements continue to be prepared on a going concern basis. Significant Accounting Policies The Company’s significant accounting policies are summarized in Note 1 of the Company’s Annual Report on Form 10-K for the year ended December 31, 2015. There were no significant changes to these accounting policies during the six months ended June 30, 2016 and the Company does not expect that the adoption of other recent accounting pronouncements will have a material impact on its financial statements.

Intangibles

Intangibles	6 Months Ended
	Jun. 30, 2016
Intangibles [Abstract]
INTANGIBLES	2. INTANGIBLES The MPL License Agreement The MPL License Agreement, under which the Company's wholly-owned subsidiary, Elite, is the licensee pursuant to the Assignment from WMA, provides for the license of medical services, operational systems, manuals, certain names and logo designs and other intellectual property in connection with the operation of medical clinics that provide services related to men’s health within the territory of the continental United States (the “Licensed Rights”). The License Agreement provides for a fee of 6% of gross receipts of Licensee, payable quarterly. The term of the License Agreement is for twenty (20) years from the effective date, May 9, 2011. The Company plans to establish new medical clinics or acquire existing clinics, as well as to provide consulting services to medical clinics utilizing the Licensed Rights. Intangibles are the value of the MPL license. Amounts assigned to this intangible were determined by management. Management considered a number of factors in determining the allocations, including valuations and independent appraisals. The intangibles are being amortized over 19.5 years, the life of the license. The components of intangible assets are as follows: License Agreements Balance January 1, 2015 $ 88,893 Amortization for the year ended December 31, 2015 (5,555 ) Balance December 31, 2015 83,338 Amortization for the six months ended June 30, 2016 2,776 Balance June 30, 2016 $ 80,562 Amortization expense for the six months ended June 30, 2016 and 2015 amounted to $2,776 and $2,778, respectively. Estimated amortization expense for intangible assets for the next five years is as follows: Year Ending Amortization December 31, Expense 2016 2,779 2017 5,555 2018 5,555 2019 5,555 2020 5,555

Loan Receivable-Related Party

Loan Receivable-Related Party	6 Months Ended
	Jun. 30, 2016
Loan Receivable-Related Party [Abstract]
LOAN RECEIVABLE-RELATED PARTY	3. LOAN RECEIVABLE-RELATED PARTY The Company advanced operating funds on a short-term basis to the MedCure Companies during the year ended December 31, 2015. The Company advanced the MedCure Companies $180,000 and received repayments of $80,000. During the six months ended June 30, 2016, the Company advanced an additional $775,181 and received repayments of $265,000. As of June 30, 2016 and December 31, 2015, the MedCure Companies owed the Company $610,181 and $100,000, respectively.

Property and Equipment

Property and Equipment	6 Months Ended
	Jun. 30, 2016
Property and Equipment [Abstract]
PROPERTY AND EQUIPMENT	4 PROPERTY AND EQUIPMENT Property and equipment consists of the following: June 30, December 31, 2016 2015 Equipment $ 432,152 $ 157,152 Accumulated depreciation 55,291 22,856 $ 376,861 $ 134,296 Depreciation expense for the six months ended June 30, 2016 and 2015 was $32,435 and $6,912, respectively.

Debt

Debt	6 Months Ended
	Jun. 30, 2016
Debt [Abstract]
DEBT	5. DEBT Short-term debt as of June 30, 2016 and December 31, 2015 were as follows: June 30, December 31, 2016 2015 Short-term Debt Secured promissory note, interest 12% per annum, due December 31, 2016 $ 150,000 $ 150,000 Unsecured promissory note, interest 10%, due December 31, 2016 75,000 75,000 Convertible promissory note, interest 10% per annum, due November, 2016 100,000 100,000 Convertible promissory note, interest 12% per annum, due April 28, 2017 and June 8, 2017 (2) 255,746 431,465 Convertible promissory note, interest 12% per annum, due December 17, 2016 100,000 100,000 Convertible promissory note, interest 10% per annum, due September 23, 2016 38,355 12,600 Unsecured promissory note, interest 10% per annum, due November 1, 2016 25,000 25,000 Unsecured promissory note, interest 10% per annum, due August 15, 2016 (1) 6,000 - Secured promissory note, interest 6% per anum due April 1, 2017 (4) 275,000 - Convertible promissory note, interest 12% per annum, due June 13, 2017 (3) 234,407 - 1,259,508 894,065 Less: Current portion 1,259,508 894,065 $ - $ - (1) On February 18, 2016, the Company executed an unsecured promissory note with Gail Keats and received $30,000. The promissory note bears interest at 10% per annum and both principal and interest are payable on or before August 15, 2016. The Company paid $24,000 against the note as of June 30, 2016 and an additional $6,000 in July 2016. (2) On May 16, 2016, the Company amended its loan agreements with Roy Meadows (“Meadows”). The Company agreed to pay Meadows a renewal fee of $28,000 and $27,956 on its two outstanding loans with Meadows and extend the maturity dates of the loans to April 28, 2017 and June 8, 2017, respectively. The new outstanding balances of the loans including interest and the renewal fees amounted to $308,000 and $307,520, respectively. The Company also agreed to amend the conversion price of the loans into the Company’s common stock to $0.10 per share. At any time, the holder of the notes, at his option, shall have the right to convert the outstanding principal balance or any portion of the principal amount hereof, and any accrued interest into shares of common stock of the Company. The fair value of the common stock at the date of issuance of the advance was $0.13, which created a Beneficial Conversion Feature of $409,766, the Beneficial Conversion feature was recorded as a debt discount over the life of the notes. The debt discount as of June 30, 2016 was $359,433. The Company performed an analysis under ASC 470-50 criteria to determine if the note extension agreement falls under debt modification or debt extinguishment criteria. The Company revalued the warrants issued and agreed the additional consideration, extended maturity dates and interest to the extended agreement. The Company deems that based on the analysis performed, debt extinguishment does exist and recorded loss on debt extinguishment in the amount of $61,697. (3) On June 13, 2016, the Company issued a convertible promissory note to Meadows and received proceeds of $250,000.The promissory note bears interest 12% per annum and matures one year from the date of issuance. At any time, the holder of the note, at his sole option, shall have the right to convert the outstanding principal amount of this note, or any portion of the principal hereof, and any accrued interest into shares of common stock of the Company, at a conversion price of $0.15 per share. (4) On April 1, 2017, the Company issued a secured promissory note to Emile Fares, M,D, (the “Payee”) and promised to the Payee $275,000 in exchange for all the medical equipment owned by RMC Totalcare Medical PA.. The secured promissory note bears interest 6% per anum and matures one year from the date issuance. A payment of $75,000 is due October 1, 2016 and the balance due on the maturity date. The note is secured by all collections received by LifeStyle Texas Medical Management LLC pursuant to a Management Agreement with RMC Totoalcare Medical PA. Interest expense for the six months ended June 30, 2016 and 2015 amounted to $63,170 and $32,450, respectively.

Accounts Payable and Accrued Ex

Accounts Payable and Accrued Expenses	6 Months Ended
	Jun. 30, 2016
Accounts Payable and Accrued Expenses [Abstract]
Accounts payable and accrued expenses	6. ACCOUNTS PAYABLE AND ACCRUED EXPENSES June 30, December 31, 2016 2015 Interest $ 72,413 $ 68,807 Salaries - Officer - 1,125 Professional fees 96,901 64,306 Consulting 118,800 48,000 Other 13,551 15,639 $ 301,665 $ 197,877

Basic and Diluted Earnings per

Basic and Diluted Earnings per Share	6 Months Ended
	Jun. 30, 2016
Basic and Diluted Earnings per Share [Abstract]
BASIC AND DILUTED EARNINGS PER SHARE	7. BASIC AND DILUTED EARNINGS PER SHARE Basic earnings per share is computed by dividing net income by the weighted-average number of common shares outstanding during the period. Diluted earnings per share is computed by dividing net earnings by the weighted-average number of common shares and dilutive potential common shares outstanding during the period. At June 30, 2016, there were 10,820,621 potential common shares. Because of the net loss, the effect of these potential common shares is anti-dilutive.

Warrants

Warrants	6 Months Ended
	Jun. 30, 2016
Warrants [Abstract]
WARRANTS	8. WARRANTS On April 1, 2016, the Company issued a warrant to Harcharan Narang M.D. to purchase 800,000 shares of the Company’s at an exercise price of $0.20 per share. The warrant was issued in connection with services provided to the Company. The fair value of the warrant was $80,000, all of which was expensed during the six months ended June 30, 2016. On May 16, 2016, the Company issued a warrant to Roy Meadows to purchase 1,059,564 shares of the Company’s common stock at an exercise price of $0.025 per share. The purchase warrant consist of a bonus warrant of 500,000 shares and a renewal warrant of 559,564 shares issued in connection with the extension of two Meadows’ notes. The fair value of the warrants amounted to $112,555, of which $13,877 was expensed as interest during the six months ended June 30, 2016. On June 30, 2016, the Company issued a warrant to Roy Meadows to purchase 250,000 shares of the Company’s common stock at an exercise price of $0.025 per share. The warrant was issued in connection with a financing provided to the Company. The fair value of the warrant was $16,355, of which $762 was expensed during the six months ended June 30, 2016. The estimated value of the warrants was determined using the Black Scholes pricing model using the following assumptions: expected term of 5 to 7 years, a risk free interest rate between 1.39% and 1.72%, a dividend yield of -0- and volatility between 427% and 459%. The fair value of the warrants amounted to $208,910. The following table summarizes the changes in warrants outstanding and the related price of the shares of the Company's common stock issued to non-employees of the Company. The warrants were granted in lieu of cash compensation for services performed. Exercise Remaining Intrinsic Shares Price Life Value Outstanding, January 1, 2016 8,000,000 $ 0.13 4.6 Granted 2,109,564 0.16 5.0 Expired/Cancelled - - Exercised - - Outstanding-period ending June 30, 2016 10,109,564 $ 0.12 4.8 years $ 63,339 Exercisable-period ending June 30, 2016 10,109,564 $ 0.12 4.8 years $ 63,339

Related Party Transactions

Related Party Transactions	6 Months Ended
	Jun. 30, 2016
Related Party Transactions [Abstract]
RELATED PARTY TRANSACTIONS	9. RELATED PARTY TRANSACTIONS a) Dr. Ronald Moomaw (“Moomaw”), a director of the Company, is the sole owner of the MED-CURE Companies. The Company received a majority of its revenue for the six months ended June 30, 2016 from the MED-Cure Companies. In connection with the management of the Med-Cure Companies, Moomaw was issued a warrant for the purchase of 5,000,000 shares of the Company’s common stock valued $465,000, the fair value at the time of issuance. Moomaw also received consulting fees of $70,800 and $10,800 for the six months ended June 30, 2016 and 2015, respectively, as part of his management compensation. b) The Company advanced operating funds on a short-term basis to the MED-CURE Companies and received payments during the six months ended June 30, 2016 and the year ended December 31, 2015. As of June 30, 2016 and December 31, 2015, the MED-CURE Companies owe the Company $610,181 and $100,000, respectively.

Common Stock

Common Stock	6 Months Ended
	Jun. 30, 2016
Common Stock [Abstract]
COMMON STOCK	10. COMMON STOCK On June 15, 2016, the Company issued 100,000 shares of the Company’s common stock to LKB Partners LLC in connection with a service agreement with the Company. The fair value of the common stock issued was $8,000, of which $6,000 was expensed during the six months ended June 30, 2016. On June 15, 2016, the Company issued 200,000 shares of the Company’s common stock to Harcharan Narang M.D. in connection with a service agreement with the Company. The fair value of the common stock issued was $16,000, all of which was expensed during the six months ended June 30, 2016.

Major Customers

Major Customers	6 Months Ended
	Jun. 30, 2016
Major Customers [Abstract]
MAJOR CUSTOMERS	11. MAJOR CUSTOMERS 100% of the revenues for the six months ended June 30, 2016, was received from companies owned 100% by Dr. Ronald Moomaw, a director of the Company.

Commitments and Contingencies

Commitments and Contingencies	6 Months Ended
	Jun. 30, 2016
Commitments and Contingencies [Abstract]
COMMITMENTS AND CONTINGENCIES	12. COMMITMENTS AND CONTINGENCIES Consulting Agreements a) During 2015 and 2014, Lifestyle entered into various consulting agreements with third parties in connection with business advisory services. For the six months ended June 30, 2016 and 2015, consulting services amounted to $87,501 and $71,987, respectively. b) On July 1, 2012, Lifestyle entered into an employment agreement with Christopher Smith("Smith"), the Company's Chief Executive Officer. The term of the agreement is for five years. Effective August 1, 2015, the monthly salary for Smith was increased to $12,500. Smith will also receive a performance bonus based on a percentage of the Company's net operating profit before income taxes. For the six months ended June 30, 2016, and 2015, payroll-officer amounted to $75,000 and $30,000, respectively.

Intangibles (Tables)

Intangibles (Tables)	6 Months Ended
	Jun. 30, 2016
Intangibles [Abstract]
Components of intangible assets	License Agreements Balance January 1, 2015 $ 88,893 Amortization for the year ended December 31, 2015 (5,555 ) Balance December 31, 2015 83,338 Amortization for the six months ended June 30, 2016 2,776 Balance June 30, 2016 $ 80,562
Schedule of estimated amortization expense for intangible assets	Year Ending Amortization December 31, Expense 2016 2,779 2017 5,555 2018 5,555 2019 5,555 2020 5,555

Property and Equipment (Tables)

Property and Equipment (Tables)	6 Months Ended
	Jun. 30, 2016
Property and Equipment [Abstract]
Schedule of property and equipment	June 30, December 31, 2016 2015 Equipment $ 432,152 $ 157,152 Accumulated depreciation 55,291 22,856 $ 376,861 $ 134,296

Debt (Tables)

Debt (Tables)	6 Months Ended
	Jun. 30, 2016
Debt [Abstract]
Summary of short-term debt	June 30, December 31, 2016 2015 Short-term Debt Secured promissory note, interest 12% per annum, due December 31, 2016 $ 150,000 $ 150,000 Unsecured promissory note, interest 10%, due December 31, 2016 75,000 75,000 Convertible promissory note, interest 10% per annum, due November, 2016 100,000 100,000 Convertible promissory note, interest 12% per annum, due April 28, 2017 and June 8, 2017 (2) 255,746 431,465 Convertible promissory note, interest 12% per annum, due December 17, 2016 100,000 100,000 Convertible promissory note, interest 10% per annum, due September 23, 2016 38,355 12,600 Unsecured promissory note, interest 10% per annum, due November 1, 2016 25,000 25,000 Unsecured promissory note, interest 10% per annum, due August 15, 2016 (1) 6,000 - Secured promissory note, interest 6% per anum due April 1, 2017 (4) 275,000 - Convertible promissory note, interest 12% per annum, due June 13, 2017 (3) 234,407 - 1,259,508 894,065 Less: Current portion 1,259,508 894,065 $ - $ -

Accounts Payable and Accrued 21

Accounts Payable and Accrued Expenses (Tables)	6 Months Ended
	Jun. 30, 2016
Accounts Payable and Accrued Expenses [Abstract]
Schedule of accounts payable and accrued expenses	June 30, December 31, 2016 2015 Interest $ 72,413 $ 68,807 Salaries - Officer - 1,125 Professional fees 96,901 64,306 Consulting 118,800 48,000 Other 13,551 15,639 $ 301,665 $ 197,877

Warrants (Tables)

Warrants (Tables)	6 Months Ended
	Jun. 30, 2016
Warrants [Abstract]
Schedule of changes in warrants outstanding	Exercise Remaining Intrinsic Shares Price Life Value Outstanding, January 1, 2016 8,000,000 $ 0.13 4.6 Granted 2,109,564 0.16 5.0 Expired/Cancelled - - Exercised - - Outstanding-period ending June 30, 2016 10,109,564 $ 0.12 4.8 years $ 63,339 Exercisable-period ending June 30, 2016 10,109,564 $ 0.12 4.8 years $ 63,339

Intangibles (Details)

Intangibles (Details) - USD ($)	6 Months Ended		12 Months Ended
	Jun. 30, 2016	Jun. 30, 2015	Dec. 31, 2015
Components of intangible assets
Intangible assets, beginning balance	$ 83,338
Amortization	2,776	$ 2,778
Intangible assets, ending balance	80,562		$ 83,338
MPL License Agreement [Member]
Components of intangible assets
Intangible assets, beginning balance	83,338	$ 88,893	88,893
Amortization	2,776		(5,555)
Intangible assets, ending balance	$ 80,562		$ 83,338

Intangibles (Details 1)

Intangibles (Details 1)	Jun. 30, 2016USD ($)
Estimated amortization expense for intangible assets
2,016	$ 2,779
2,017	5,555
2,018	5,555
2,019	5,555
2,020	$ 5,555

Intangibles (Details Textual)

Intangibles (Details Textual) - USD ($)	6 Months Ended
	Jun. 30, 2016	Jun. 30, 2015
Intangible (Textual)
Fee of gross receipts of licensee, Percentage	6.00%
Term of license agreement	20 years
Amortization period of license agreement	19 years 6 months
Amortization expense	$ 2,776	$ 2,778

Loan Receivable-Related Party (

Loan Receivable-Related Party (Details) - USD ($)	6 Months Ended		12 Months Ended
	Jun. 30, 2016	Jun. 30, 2015	Dec. 31, 2015
Loan Receivable-Related Party (Textual)
Advances to related party	$ 775,181		$ 180,000
Repayments of related party debt	265,000	$ 80,000	80,000
Loan receivable-related party	$ 610,181		$ 100,000

Property and Equipment (Details

Property and Equipment (Details) - USD ($)	Jun. 30, 2016	Dec. 31, 2015
Property and Equipment [Abstract]
Equipment	$ 432,152	$ 157,152
Accumulated depreciation	55,291	22,856
Property and equipment,net	$ 376,861	$ 134,296

Property and Equipment (Detai28

Property and Equipment (Details Textual) - USD ($)	6 Months Ended
	Jun. 30, 2016	Jun. 30, 2015
Property and Equipment (Textual)
Depreciation expense	$ 32,435	$ 6,912

Debt (Details)

Debt (Details) - USD ($)		Jun. 30, 2016		Dec. 31, 2015
Short-term Debt [Line Items]
Short-term debt		$ 1,259,508		$ 894,065
Less: Current portion		1,259,508		894,065
Short-term debt, Net
Secured promissory note, interest @ 12% per annum, due December 31, 2016
Short-term Debt [Line Items]
Short-term debt		150,000		150,000
Unsecured promissory note, interest @ 10%, due December 31, 2016
Short-term Debt [Line Items]
Short-term debt		75,000		75,000
Convertible promissory note, interest @ 10% per annum, due November, 2016
Short-term Debt [Line Items]
Short-term debt		100,000		100,000
Convertible promissory note, interest @ 12% per annum, due April 28, 2017 and June 8, 2017 (2)
Short-term Debt [Line Items]
Short-term debt	[1]	255,746		431,465
Convertible promissory note, interest @ 12% per annum, due December 17, 2016
Short-term Debt [Line Items]
Short-term debt		100,000		100,000
Convertible promissory note, interest @ 10% per annum, due September 23, 2016
Short-term Debt [Line Items]
Short-term debt		38,355		12,600
Unsecured promissory note, interest @ 10% per annum, due November 1, 2016
Short-term Debt [Line Items]
Short-term debt		25,000		25,000
Unsecured promissory note, interest @ 10% per annum, due August 15, 2016 (1)
Short-term Debt [Line Items]
Short-term debt		6,000	[2]		[3]
Secured promissory note, interest @ 6% per anum due April 1, 2017 (4)
Short-term Debt [Line Items]
Short-term debt		275,000	[3]		[4]
Convertible promissory note, interest @ 12% per annum, due June 13, 2017 (3)
Short-term Debt [Line Items]
Short-term debt	[4]	$ 234,407
[1]	On May 16, 2016, the Company amended its loan agreements with Roy Meadows ("Meadows"). The Company agreed to pay Meadows a renewal fee of $28,000 and $27,956 on its two outstanding loans with Meadows and extend the maturity dates of the loans to April 28, 2017 and June 8, 2017, respectively. The new outstanding balances of the loans including interest and the renewal fees amounted to $308,000 and $307,520, respectively. The Company also agreed to amend the conversion price of the loans into the Company's common stock to $0.10 per share. At any time, the holder of the notes, at his option, shall have the right to convert the outstanding principal balance or any portion of the principal amount hereof, and any accrued interest into shares of common stock of the Company. The fair value of the common stock at the date of issuance of the advance was $0.13, which created a Beneficial Conversion Feature of $409,766, the Beneficial Conversion feature was recorded as a debt discount over the life of the notes. The debt discount as of June 30, 2016 was $359,433. The Company performed an analysis under ASC 470-50 criteria to determine if the note extension agreement falls under debt modification or debt extinguishment criteria. The Company revalued the warrants issued and agreed the additional consideration, extended maturity dates and interest to the extended agreement. The Company deems that based on the analysis performed, debt extinguishment does exist and recorded loss on debt extinguishment in the amount of $61,697.
[2]	On February 18, 2016, the Company executed an unsecured promissory note with Gail Keats and received $30,000. The promissory note bears interest at 10% per annum and both principal and interest are payable on or before August 15, 2016. The Company paid $24,000 against the note as of June 30, 2016 and an additional $6,000 in July 2016.
[3]	On April 1, 2017, the Company issued a secured promissory note to Emile Fares, M,D, (the "Payee") and promised to the Payee $275,000 in exchange for all the medical equipment owned by RMC Totalcare Medical PA.. The secured promissory note bears interest @ 6% per anum and matures one year from the date issuance. A payment of $75,000 is due October 1, 2016 and the balance due on the maturity date. The note is secured by all collections received by LifeStyle Texas Medical Management LLC pursuant to a Management Agreement with RMC Totoalcare Medical PA.
[4]	On June 13, 2016, the Company issued a convertible promissory note to Meadows and received proceeds of $250,000.The promissory note bears interest @ 12% per annum and matures one year from the date of issuance. At any time, the holder of the note, at his sole option, shall have the right to convert the outstanding principal amount of this note, or any portion of the principal hereof, and any accrued interest into shares of common stock of the Company, at a conversion price of $0.15 per share.

Debt (Details Textual)

Debt (Details Textual)	Apr. 01, 2017USD ($)	Jun. 13, 2016USD ($)$ / shares	May 16, 2016USD ($)$ / shares	Feb. 18, 2016USD ($)	Jul. 30, 2016USD ($)	Jun. 30, 2016USD ($)	Jun. 30, 2015USD ($)	Jun. 30, 2016USD ($)OutstandingLoan	Jun. 30, 2015USD ($)
Debt (Textual)
Beneficial conversion feature								$ 426,121	$ 40,000
Loss on extinguishment of debt						$ 61,697		61,697
Interest expense								$ 63,170	$ 32,450
Secured promissory note, interest @ 12% per annum, due December 31, 2016
Debt (Textual)
Debt instrument interest rate						12.00%		12.00%
Debt instrument, maturity date								Dec. 31, 2016
Unsecured promissory note, interest @ 10%, due December 31, 2016
Debt (Textual)
Debt instrument interest rate						10.00%		10.00%
Debt instrument, maturity date								Dec. 31, 2016
Convertible promissory note, interest @ 10% per annum, due November, 2016
Debt (Textual)
Debt instrument interest rate						10.00%		10.00%
Debt instrument, maturity date								Nov. 30, 2016
Convertible promissory note, interest @ 12% per annum, due April 28, 2017
Debt (Textual)
Debt instrument interest rate						12.00%		12.00%
Debt instrument, maturity date								Apr. 28, 2017
Number of outstanding loans | OutstandingLoan								2
Convertible promissory note, interest @ 12% per annum, due April 28, 2017 | Roy Meadows [Member]
Debt (Textual)
Conversion price | $ / shares			$ 0.10
Fair value of common stock advance per share | $ / shares			$ 0.13
Beneficial conversion feature			$ 409,766
Debt discount								$ 359,433
Convertible promissory note, interest @ 12% per annum, due April 28, 2017 | Outstanding Loan One [Member] | Roy Meadows [Member]
Debt (Textual)
Debt instrument, maturity date			Apr. 28, 2017
Renewal fee amount			$ 28,000
Outstanding loans including interest and renewal fees			$ 308,000
Convertible promissory note, interest @ 12% per annum, due April 28, 2017 | Outstanding Loan Two [Member] | Roy Meadows [Member]
Debt (Textual)
Debt instrument, maturity date			Jun. 8, 2017
Renewal fee amount			$ 27,956
Outstanding loans including interest and renewal fees			$ 307,520
Convertible promissory note, interest @ 12% per annum, due June 8, 2017
Debt (Textual)
Debt instrument interest rate						12.00%		12.00%
Debt instrument, maturity date								Jun. 8, 2017
Convertible promissory note, interest @ 12% per annum, due December 17, 2016
Debt (Textual)
Debt instrument interest rate						12.00%		12.00%
Debt instrument, maturity date								Dec. 17, 2016
Convertible promissory note, interest @ 10% per annum, due September 23, 2016
Debt (Textual)
Debt instrument interest rate						10.00%		10.00%
Debt instrument, maturity date								Sep. 23, 2016
Unsecured promissory note, interest @ 10% per annum, due November 1, 2016
Debt (Textual)
Debt instrument interest rate						10.00%		10.00%
Debt instrument, maturity date								Nov. 1, 2016
Unsecured promissory note, interest @ 10% per annum, due August 15, 2016
Debt (Textual)
Debt instrument interest rate				10.00%		10.00%		10.00%
Debt instrument, maturity date								Aug. 15, 2016
Proceeds from unsecured promissory note with Gail Keats				$ 30,000
Payments against the note								$ 24,000
Secured promissory note, interest @ 6% per anum due April 1, 2017
Debt (Textual)
Debt instrument interest rate						6.00%		6.00%
Debt instrument, maturity date								Apr. 1, 2017
Convertible promissory note, interest @ 12% per annum, due June 13, 2017
Debt (Textual)
Debt instrument interest rate						12.00%		12.00%
Debt instrument, maturity date								Jun. 13, 2017
Convertible promissory note, interest @ 12% per annum, due June 13, 2017 | Roy Meadows [Member]
Debt (Textual)
Debt instrument interest rate		12.00%
Conversion price | $ / shares		$ 0.15
Proceeds from convertible promissory note		$ 250,000
Subsequent Event [Member] | Unsecured promissory note, interest @ 10% per annum, due August 15, 2016
Debt (Textual)
Payments of additional debt					$ 6,000
Subsequent Event [Member] | Secured promissory note, interest @ 6% per anum due April 1, 2017
Debt (Textual)
Debt instrument interest rate	6.00%
Debt instrument, maturity date	Oct. 1, 2016
Secured promissory note	$ 275,000
Payments of debt	$ 75,000

Accounts Payable and Accrued 31

Accounts Payable and Accrued Expenses (Details) - USD ($)	Jun. 30, 2016	Dec. 31, 2015
Accounts Payable and Accrued Expenses [Abstract]
Interest	$ 72,413	$ 68,807
Salaries - Officer		1,125
Professional fees	96,901	64,306
Consulting	118,800	48,000
Other	13,551	15,639
Accounts payable and Accrued expenses, Total	$ 301,665	$ 197,877

Basic and Diluted Earnings pe32

Basic and Diluted Earnings per Share (Details)	6 Months Ended
	Jun. 30, 2016shares
Basic and Diluted Earnings Per Share (Textual)
Anti-dilutive shares	10,820,621

Warrants (Details)

Warrants (Details) - Warrants [Member]	6 Months Ended
	Jun. 30, 2016USD ($)$ / sharesshares
Shares
Outstanding, Beginning Balance | shares	8,000,000
Granted | shares	2,109,564
Expired/Cancelled | shares
Exercised | shares
Outstanding, Ending Balance | shares	10,109,564
Exercisable | shares	10,109,564
Exercise Price
Outstanding, Beginning Balance | $ / shares	$ 0.13
Granted | $ / shares	0.16
Expired/Cancelled | $ / shares
Exercised | $ / shares
Outstanding, Ending Balance | $ / shares	0.12
Exercisable | $ / shares	$ 0.12
Remaining Life
Outstanding, Beginning Balance	4 years 7 months 6 days
Granted	5 years
Exercisable	4 years 9 months 18 days
Outstanding, Ending Balance	4 years 9 months 18 days
Intrinsic Value
Outstanding, Ending Balance | $	$ 63,339
Exercisable | $	$ 63,339

Warrants (Details Textual)

Warrants (Details Textual) - Warrant [Member] - USD ($)	May 16, 2016	Mar. 31, 2016	Jun. 30, 2016
Warrants (Textual)
Fair value of warrants			$ 208,910
Dividend yield			0.00%
Maximum [Member]
Warrants (Textual)
Expected term			7 years
Risk free interest rate			1.72%
Volatility			459.00%
Minimum [Member]
Warrants (Textual)
Expected term			5 years
Risk free interest rate			1.39%
Volatility			427.00%
Roy Meadows [Member]
Warrants (Textual)
Issuance of warrant to purchase common stock	1,059,564
Exercise price	$ 0.025
Bonus warrant	500,000
Renewal warrant	559,564
Fair value of warrants	$ 112,555
Interest expense			$ 13,877
Roy Meadows [Member] | Financing [Member]
Warrants (Textual)
Issuance of warrant to purchase common stock			250,000
Exercise price			$ 0.025
Fair value of warrants			$ 16,355
Interest expense			$ 762
Harcharan Narang M.D [Member]
Warrants (Textual)
Issuance of warrant to purchase common stock		800,000
Exercise price		$ 0.20
Fair value of warrants		$ 80,000

Related Party Transactions (Det

Related Party Transactions (Details) - USD ($)	6 Months Ended
	Jun. 30, 2016	Jun. 30, 2015	Dec. 31, 2015
Related Party Transactions (Textual)
Companies owe amount	$ 610,181		$ 100,000
Med Cure Companies [Member]
Related Party Transactions (Textual)
Issuance of warrant to purchase common stock	5,000,000
Fair value of warrant	$ 465,000
Moomaw received consulting fees	$ 70,800	$ 10,800

Common Stock (Details)

Common Stock (Details) - USD ($)	1 Months Ended	6 Months Ended
	Jun. 15, 2016	Jun. 30, 2016
LKB Partners LLC [Member]
Common Stock (Textual)
Common stock shares issued	100,000
Fair value of common stock issued	$ 8,000
Fair value of common stock issued expense		$ 6,000
Harcharan Narang M.D [Member]
Common Stock (Textual)
Common stock shares issued	200,000
Fair value of common stock issued	$ 16,000
Fair value of common stock issued expense		$ 16,000

Major Customers (Details)

Major Customers (Details)	6 Months Ended
	Jun. 30, 2016
Dr. Ronald Moomaw (Director) [Member]
Major Customers (Textual)
Concentration Risk, Percentage	100.00%
Sales Revenue, Net [Member]
Major Customers (Textual)
Concentration Risk, Percentage	100.00%

Commitments and Contingencies (

Commitments and Contingencies (Details Textual) - USD ($)	Jul. 01, 2012	Jun. 30, 2016	Jun. 30, 2015
Employment Agreement [Member]
Commitments and Contingencies (Textual)
Term of employment agreement	5 years
Amount of compensation as per payroll - officer		$ 75,000	$ 30,000
Monthly salaries	$ 12,500
Consulting Agreements [Member] | Related Party Consulting Services [Member]
Commitments and Contingencies (Textual)
Consulting fees		$ 87,501	$ 71,987